Hemostasis Valve Market Size Worth USD 339.88 Million by 2034 | CAGR: 6.1%

The hemostasis valve market size is expected to reach USD 339.88 million by 2034, according to a new study by Polaris Market Research. The report “Hemostasis Valve Market Size, Share, Trends, Industry Analysis Report By Type (Hemostasis Valve Y- Connectors, Double Y- Connector Hemostasis Valves), By Application, By End Use, By Region– Market Forecast, 2026–2034” gives a detailed insight into current market dynamics and provides analysis on future market growth.

A hemostasis valve is a medical device used during catheter-based interventional procedures to prevent blood loss while allowing instruments to pass through vascular access sites. It typically features a sealing mechanism that maintains hemostasis when guidewires, catheters, or other devices are introduced or withdrawn.

Global investments in healthcare infrastructure, especially in emerging markets, are expanding access to advanced interventional procedures. Governments and private organizations are increasing spending on hospitals, cath labs, and diagnostic centers equipped with modern equipment. The need for reliable tools such as hemostasis valves grows with better access to facilities capable of performing high-volume catheter-based procedures. Moreover, training programs and workshops in developing regions are raising awareness and adoption of advanced interventional practices. This growth in healthcare infrastructure creates a broader base of end users for hemostasis valves, driving steady market expansion.

Bottom of Form

Have Questions? Request a sample or make an inquiry before buying this report by clicking the link below: Download Sample Report

Many manufacturers offer hemostasis valves as part of complete interventional procedure packs, which include syringes, introducers, and other sterile tools required for catheterization. These ready-to-use kits simplify logistics, reduce preparation time, and enhance workflow efficiency in busy clinical environments. By bundling valves into procedure packs, healthcare providers can standardize care, reduce costs, and improve safety through consistent equipment usage. This integrated approach appeals to hospitals and clinics seeking streamlined solutions, boosting overall sales of hemostasis valves and supporting long-term market growth through convenience and compatibility.

Hemostasis Valve Market Report Highlights

• North America dominated with the largest share of 41.5% in 2025. The regional market dominance is driven by a high volume of cardiovascular procedures and advanced interventional healthcare infrastructure.
• The market in the U.S. is expected to witness significant growth at a 6.7% CAGR. This is due to its high healthcare spending, large aging population affected by cardiovascular diseases, and increasing adoption of minimally invasive procedures.
• Asia Pacific is projected to witness substantial growth at a 7.2% CAGR. This is primarily due to increasing healthcare investments, expanding access to minimally invasive procedures, and improving catheterization laboratory infrastructure.
• The hemostasis valve Y-connectors segment dominated with the largest share of 57.8% in 2025. The segment’s dominance is attributed to its widespread use across angioplasty, angiography, and other interventional procedures.
• The one-handed hemostasis valves segment is expected to experience significant growth at a 7.5% CAGR. This is owing to its ergonomic design, ease of operation, and enhanced procedural efficiency during catheter-based interventions.
• A few global key market players are Abbott; Antmed Corporation; Argon Medical Devices; B. Braun Melsungen AG; Beijing Demax Medical Technology Co.; Boston Scientific Corporation; DeRoyal Industries, Inc.; Freudenberg Medical; Lepu Medical Technology (Beijing) Co., Ltd.; Merit Medical Systems; Nipro; SCW Medicath Ltd.; Teleflex Incorporated; and TERUMO CORPORATION.

Polaris Market Research has segmented the hemostasis valve market report on the basis of type, application, end use, and region:

By Type (Revenue – USD Million, 2021–2034)

• Hemostasis Valve Y- Connectors
• Double Y- Connector Hemostasis Valves
• One- Handed Hemostasis Valves
• Others

By Application (Revenue – USD Million, 2021–2034)

• Angiography
• Angioplasty

By End Use (Revenue – USD Million, 2021–2034)

• Hospitals
• Ambulatory Surgical Centers
• Others

By Regional Outlook (Revenue – USD Million, 2021–2034)

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Rest of Asia Pacific
• Latin America
  • Argentina
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa